ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JENNIFER WEINRAUB MD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,560Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 2680

$205K Total Retail Price of All Prescriptions

Rank: 1423 out of 2680

338 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 338 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 15,862 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$12 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 529 497 1 2
FUROSEMIDE 514 506 2 7
LISINOPRIL 486 471 3 5
ATORVASTATIN CALCIUM 471 435 4 10
ASPIRIN EC 447 438 5 199
LEVOTHYROXINE SODIUM 440 417 6 4
DONEPEZIL HCL 437 437 7 28
SENNA 427 420 10 8 242
CALCIUM 600 + VIT D 408 389 10 9 204
TRAMADOL HCL 375 375 10 33
NAMENDA 333 328 11 43
PAIN RELIEVER 332 330 10 12 213
LORATADINE 316 310 13 259
AMLODIPINE BESYLATE 287 268 14 3
POTASSIUM CHLORIDE 261 222 15 29
CYMBALTA 242 242 16 56
SERTRALINE HCL 230 228 17 23
MIRTAZAPINE 208 208 18 48
METOPROLOL TARTRATE 196 196 19 8
TAMSULOSIN HCL 187 187 20 25
FLUOXETINE HCL 186 146 21 76
FERROUS SULFATE 184 184 22 289
CITALOPRAM HBR 174 174 23 22
VITAMIN D2 173 154 24 176
METOPROLOL SUCCINATE 170 170 25 11
ASPIRIN 167 166 26 240
SENNA S 162 144 27 303
ALENDRONATE SODIUM 137 120 28 20
CALMOSEPTINE 133 133 10 29 285
ATENOLOL 128 128 30 14
HYDROCHLOROTHIAZIDE 128 128 30 9
DAILY VITE 124 124 32 318
DOC-Q-LACE 120 120 10 33 449
VITAMIN B-12 117 112 34 271
LOSARTAN POTASSIUM 116 116 35 18
OYSTER SHELL CALCIUM W-VIT D 105 105 36 338
WARFARIN SODIUM 104 104 37 12
D3-50 100 92 10 38 338
SIMVASTATIN 100 99 38 1
SPIRIVA 99 83 40 36
CALCIUM 94 59 10 41 391
ARTIFICIAL TEARS 92 88 42 389
ALBUTEROL SULFATE 91 91 43 97
ALLOPURINOL 87 87 44 42
CLOPIDOGREL 83 83 45 30
DILTIAZEM 24HR CD 81 81 46 148
HYDROCODONE-ACETAMINOPHEN 81 67 S3 46 13
GABAPENTIN 80 80 48 21
RANITIDINE HCL 78 78 49 35
GLIPIZIDE 77 65 50 71
SINGULAIR 75 75 51 64
METFORMIN HCL 74 74 52 6
LIDODERM 74 74 52 74
ISOSORBIDE MONONITRATE ER 73 73 54 57
FOLIC ACID 72 72 55 330
BYSTOLIC 71 71 56 104
VENTOLIN HFA 71 56 56 61
LEVETIRACETAM 70 70 58 94
CRANBERRY 69 69 10 59 408
DETROL LA 69 69 59 217
NOVOLIN 70-30 68 68 61 277
OXYBUTYNIN CHLORIDE ER 68 58 61 135
NYSTOP 68 68 61 183
PREDNISONE 65 65 64 45
ENABLEX 64 52 65 401
QUETIAPINE FUMARATE 62 62 66 72
VITAMIN D 62 62 66 369
MAGNESIUM OXIDE 61 61 10 68 384
FINASTERIDE 61 61 68 80
ESCITALOPRAM OXALATE 61 61 68 82
PREMARIN 57 57 R 71 333
DIVALPROEX SODIUM ER 56 56 72 257
ASCORBIC ACID 55 55 10 73 544
GLIPIZIDE XL 54 53 74 87
MONTELUKAST SODIUM 54 52 74 134
ASACOL 52 52 76 468
BETHANECHOL CHLORIDE 52 52 76 379
PHENYTOIN SODIUM EXTENDED 52 15 76 207
RISPERIDONE 51 51 79 67
ADVAIR DISKUS 51 48 79 32
ACIDOPHILUS 51 51 10 79 557
PAROXETINE HCL 50 50 82 62
LANTUS SOLOSTAR 50 37 82 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.